ADAMTSL5 and nonpapillary renal cell carcinoma: We did not analyze the pathway of ADAMTSL5, ADAMTS3, ADAMTS6, and ADAMTS13 among the 8 genes used to establish the prognosis model because there was no significant difference in the expression of ADAMTSL5, ADAMTS3, ADAMTS6, and ADAMTS13 between ccRCC and normal renal tissue, or although they are risk factors, compared with normal renal tissue, their expression levels in ccRCC are lower, so there is no need for pathway analysis.